Clinical Trials · NCT07706361

Two-Part Study of the Effects of the X39 Patch on Circulating GHK and GHK-Cu Levels in Healthy Adults

Name: Two-Part Study of the Effects of the X39 Patch on Circulating GHK and GHK-Cu Levels in Healthy Adults
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

Not Yet RecruitingN/AGHK-Cu

Phase: N/A
Recruitment status: Not Yet Recruiting
Sponsor: LifeWave, Inc.
Enrollment: 100
Start date: Jan 2027
Locations: 1 site, Canada
Primary endpoint: Change in GHK levels from baseline to Day 8

View GHK-Cu compound reference